Food and Drug
Administration
Anti-Infective
Drugs Advisory Committee
March 6, 2006
Briefing Information
Cubist Pharmaceuticals,
Inc.
Disclaimer
The statements
contained in this document(s) are those of the product's sponsor,
not FDA, and FDA does not necessarily agree with the sponsor's
statements. FDA has not made a final determination about the
safety or effectiveness of the product described in this document.
Cubicin® (daptomycin for injection)
Briefing Material
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the
FOIA) (5 U.S.C. §552).
These redacted portions will appear as white space on the
screen or on the printed page.
FDA Backgrounder on Cubicin®
FDA Backgrounder Errata
FDA Backgrounder Errata 2